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Abstract Modeling brain disorders has always been one of
the key tasks in neurobiological studies. A wide range of
organisms includingworms, fruit flies, zebrafish, and rodents
have been used for modeling brain disorders. However,
whether complicated neurological and psychiatric symp-
toms can be faithfully mimicked in animals is still debatable.
In this review, we discuss key findings using non-human
primates to address the neural mechanisms underlying stress
and anxiety behaviors, as well as technical advances for
establishing genetically-engineered non-human primate
models of autism spectrum disorders and other disorders.
Considering the close evolutionary connections and simi-
larity of brain structures between non-human primates and
humans, together with the rapid progress in genome-editing
technology, non-human primates will be indispensable for
pathophysiological studies and exploring potential thera-
peutic methods for treating brain disorders.
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Introduction
Psychiatric disorders are a group of mental illnesses without
detectable pathological symptoms such as neuronal death.
They include schizophrenia, depression, bipolar disorder,
and autism spectrum disorders (ASDs). The onset of most
psychiatric disorders is normally in adulthood. However, the
onset of ASDs is during the first 3 years of life. Therefore,
ASDs are also considered to be developmental disorders,
possibly caused by disruption of neural development leading
to abnormal social behaviors and other symptoms [1].
With recent advances in human genetics and neurobio-
logical studies, ASDs have been found to include both
genetic and environmental components. Particularly,
mechanistic studies in animal models have provided
tremendous insights into how genetic and environmental
factors contribute to neural development and underlie the
proper functioning of cognitive and social behaviors. A
wide range of animal models including worms, fruit flies,
zebrafish, and rodents have been used to study neural
development and disorders. However, whether complicated
neurological and psychiatric symptoms can be faithfully
mimicked in animals other than primates is still debatable.
In this review, we discuss technical advances for studying
the neural mechanisms underlying ASDs and other brain
disorders using non-human primates as animal models.
Considering the close evolutionary connections and simi-
larity of brain structures in non-human primates and
humans, together with the rapid progress of genome-edit-
ing technology, non-human primates will be indispensable
in pathophysiological studies and potential interventions
for psychiatric disorders [2].
Pharmacological and Environmental Approaches
The general approaches used in rodents for modeling
psychiatric disorders, such as chronic restraint stress,
chronic unpredictable mild stress, and chronic social defeat
stress, are efficient for inducing anxiety-like behaviors for
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various periods of time. However, for ethical reasons, most
of these approaches are not practical in non-human pri-
mates. Under these circumstances, researchers have
designed mild stress models, in which monkeys are sub-
jected to gentle stresses. Kalin and colleagues have estab-
lished various stress models in monkeys, followed by
assessment of physiological and neurochemical parameters
[3]. After being stared by humans, infant monkeys appear
to exhibit anxiety-like activity such as aggressive barking.
Infant monkeys make distress calls when separated from
their mothers. Investigators then found, using pharmaco-
logical approaches, that the opiate and GABA systems play
different roles in regulating these behaviors, suggesting
roles of these neuromodulators in emotional behaviors in
primates [3].
With regard to the close relationships between monkeys
and humans, whether complex environmental factors can
be applied to monkeys is a critical question to address. Hu
and colleagues have designed a paradigm in which
maternal separation paradigms are mimicked in monkeys
[4]. They investigated the impact of maternal separation in
early life on social behaviors during adolescence, as well as
levels of stress hormones. Importantly, they found that
maternal separation during early life dramatically influ-
ences social behaviors and stress levels, consistent with
previous studies in humans. Further mechanistic studies
using these monkeys may elucidate the underlying circuit
basis of how early life stress affects behaviors during
adulthood. The classical methods of studying the neural
mechanisms underlying psychiatric disorders have been
nicely summarized by Suomi [5] and Watson and Platt [6].
Genetic Approaches Based on Viral Transduction
Over the years, genetic approaches have been widely
applied in model organisms, such as worms, fruit flies, and
rodents, to establish models of brain disorders. Due to the
difficulty of handling germline cells and the unavailability
of embryonic stem cells, genetic engineering in monkeys
did not become available until 2001 [7]. In this seminal
work, Chan and colleagues infected rhesus monkey (Ma-
caca mulatta) oocytes with a retrovirus harboring the green
fluorescence protein (GFP) gene, followed by in vitro fer-
tilization (IVF) with sperm. After transplantation of fer-
tilized eggs into surrogate monkeys, researchers
successfully acquired transgenic monkeys carrying the
GFP gene. This pioneering work launched a new era of
genetic engineering in non-human primates.
Taking advantage of the high efficiency of lentiviral
infection, Li, Chan, and colleagues at Emory University
used lentivirus harboring the disease-causing Huntingtin
(HTT) mutant gene to infect rhesus monkey oocytes [8].
After IVF, investigators successfully obtained several
transgenic monkeys carrying the HTT mutant gene.
Remarkably, the monkeys carrying the mutant gene
showed clear signs of neuronal death in the brain, which is
barely detectable in rodent models of Huntington disease.
Thus, for the first time, a non-human primate model of a
human brain disorder exhibited the unique advantage of
mimicking the neuropathological symptoms, which are
difficult to find in rodent models.
Another pioneering work in genetic engineering for non-
human primates was done in marmosets (Callithrix jac-
chus). Sasaki and colleagues also used lentiviral-based
methods to produce transgenic marmosets carrying GFP
transgenes [9]. Importantly, they obtained a second gen-
eration carrying the transgene, taking advantage of the
shorter reproduction in marmosets than macaques, and
indicating the reliability of transgenic monkeys as animal
models.
Given the availability of lentiviral transduction methods,
a series of transgenic monkeys have been produced during
the last several years to model various brain disorders. In
order to make monkey models of Parkinson disease, Li and
colleagues produced transgenic monkeys expressing the
mutant form of a-synuclein (A53T) [10]. Although the a-
synuclein (A53T) transgenic monkeys have not yet shown
Parkinsonism-like symptoms, such as tremor and degen-
eration of dopaminergic neurons, various cognitive defects
and neuropathology in the brain have been identified,
suggesting that a-synuclein (A53T) causes pathological
changes in the monkey brain [11].
Due to the long reproductive cycle of macaques (typi-
cally reaching sexual maturation at 4–5 years of age),
obtaining a second generation is time-consuming and
costly. In recent work on making monkey models of ASDs,
Qiu and colleagues used lentivirus-based transgenic
methods to produce transgenic monkeys with the autism
gene MECP2 and examined social and motor behaviors
associated with social interaction and cognition. They
found that MECP2 transgenic monkeys indeed exhibit
abnormal behaviors, including repetitive locomotor activ-
ity, elevated anxiety levels, and defects in social interac-
tions, which nicely mimic ASDs in human patients [12].
Remarkably, investigators applied xenograft methods to
transplant testicular tissues from one sexually immature
transgenic monkey into nude mice. After 9 months, the
testicular tissues became mature and the mature sperm
were collected for IVF. Second-generation transgenic
monkeys were obtained *3.5 years after the birth of the
first-generation transgenic monkeys, dramatically shorten-
ing the time for acquiring a second generation [12]. This
work provides a framework in which monkey models of
brain disorders can be established.
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Genetic Approaches Based on Genome-Editing
Methods
With the emergence of the CRISPR-Cas9 and TALEN
genome-editing methods from 2011, genetic engineering in
non-human primates became feasible and relatively easy.
The landmark work was done by Niu and colleagues, who
injected Cas9 mRNA along with single-guide RNA
(sgRNA) into the fertilized eggs of cynomolgus monkeys
(Macaca fascicularis) and transplanted them into surrogate
monkeys [13]. Among the newborn monkeys, researchers
identified genomic mutations in the sgRNA-targeting sites
and the cellular effects of genetic deletions. However, due
to the prolonged effective period of CRISPR/Cas9, the
mutant monkeys are normally mosaics with various
mutations, which also differ across tissues. The mosaicism
in the offspring monkeys interferes with the interpretation
of the consequences of genetic deletions caused by
CRISPR/Cas9.
In another study, Chen and colleagues used CRISPR/
Cas9 to target the dystrophin gene, mutation of which leads
to Duchenne muscular dystrophy (DMD) [14]. Although
the genetic mutation was clearly identified in sgRNA-
targeted sites of the monkey DMD gene, whether the DMD
mutation leads to behavioral abnormalities in monkeys is
yet to be determined.
To model Rett syndrome, a developmental disorder,
investigators used TALEN-based genome-editing to target
the MECP2 (methyl-CpG binding protein 2) gene in
cynomolgus monkeys [15, 16], and reported that TALEN is
also effective in inducing genomic mutations in the mon-
key genome and yield offspring carrying mutations in the
MECP2 gene. However, whether genomic mutation of
MECP2 leads to behavioral changes similar to human Rett
syndrome remains to be determined [15].
Connectomic View of the Psychiatric Brain
The rapid progress of genetic engineering in non-human
primates provides researchers with a wide platform to
study primate brains at an unimaginable scale. It is likely
that brain imaging and cognitive studies using genetically-
engineered monkeys will be available soon, and will pro-
vide causal links between genes and brain structure in the
non-human primate. An elegant example is the work by
Wang and colleagues, who investigated the effects of
ketamine on the functional brain network using magnetic
resonance imaging [17].
Although ketamine, a non-competitive N-methyl-D-
aspartate receptor antagonist, has rapid and prolonged
antidepressant effects in depressed patients after a single
dose, the underlying mechanisms by which ketamine
affects brain structure in patients are unknown. Given the
lack of models of depression in non-human primates,
researchers took another approach by giving rhesus mon-
keys a single dose of ketamine, and examining the func-
tional connectivity of the brain using magnetic resonance
imaging. They found that ketamine treatment leads to
large-scale downregulation of functional connectivity,
which is precisely opposite to the brain network in
depressed patients, suggesting that ketamine has antide-
pressant effects by affecting the global brain network. This
work remarkably illustrates the value of cutting-edge
technology such as brain imaging in studying the neural
mechanisms underlying brain disorders.
Concluding Remarks
We are in an era whenmultiple disciplines have interacted to
elucidate the mechanisms of complicated human brain dis-
orders. Given the complexity of the brain, it has always been
difficult to recapitulate the core symptoms of human brain
disorders in animal models. With the rapid development of
genetic-engineering technology, such as lentiviral trans-
duction and genome-editing, it is foreseen that non-human
primates will play a crucial role as animal models in the near
future. It is worthwhile noting that current therapeutic
methods for human brain disorders such as deep brain
stimulation and transcranial magnetic stimulation will also
need to be tested in non-human primates prior to human
trials. Therefore, non-human primate models of brain dis-
orders are also indispensable for translational studies.
Together with the technical advances in brain imaging and
non-invasive neural modulation methods such as ultrasonic
stimulation, non-human primates will playmore competitive
roles in modeling brain disorders and serve as a platform on
which researchers can seek potential therapies.
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